Pro Health Fitness

News

Antibiotic Overuse in COVID-19 Patients During Pandemic, WHO Cautions

Antibiotic Overuse in COVID-19 Patients During Pandemic

United States: This COVID-19 epidemic is still on the news but this time for “extensive” abuse of antibiotics according to the health authority’s assessment which was released recently, and which may have accelerated the development of antimicrobial resistance.

Extensive Antibiotic Use During the COVID-19 Epidemic

The group discovered that just 8 percent of COVID- 19 rehabilitated cases needed antibiotics forco-infections with bacteria. nevertheless, antibiotics were used to treat nearly 75 percent of the cases. Individuals with severe or critical COVID-19 had the greatest usage rate, averaging 81 percent.

Also the use of antibiotics did not improve all the clinical outcomes for the COVID-19 patients according to WHO and apart from that when the patient requires antibiotics, the benefit of it often outweigh the risks associated with the side effects or antibiotic resistance, however they are unnecessary,  they offer no benefits when they possess any kind of risk and their use contributes to the emergence and spread of antimicrobial resistance explained the Silvia Bertagnolio of WHO said in a statement. “These data call for improvements in the rational use of antibiotics to minimize unnecessary negative consequences for patients and populations.”

Limited Clinical Benefits and Risks of Antibiotic Administration

The results are based on information gathered from over 450,000 hospitalized COVID-19 patients in 65 different countries between January 2020 and March 2023.

As per the Centers for Disease Control and Prevention, antimicrobial resistance is a” critical global public health trouble” that claimed the lives of at least1.27 million people encyclopedically in 2019.

Global Implications and Need for Improved Antibiotic Prescribing

Visual Representation of Antibiotic. Credit | Shutterstock

The CDC stated on its website that” antimicrobial resistance happens when origins like bacteria and fungi develop the capability to master the medicines designed to kill them.” This implies that the bacteria survive and gain. Treatment for resistant infections can be grueling and occasionally unattainable.

According to a statement from Yukiko Nakatani of WHO, the results “underscore the important need to adequately resource the efforts to improve antibiotic prescribing globally.”

Leave a Reply

Your email address will not be published. Required fields are marked *